Precision Medicine in Solid Tumors

Precision Medicine in Solid Tumors

In the era of precision medicine, the use of molecularly targeted therapies in selected patients has led to a paradigm change in cancer treatment. Multiple studies have demonstrated the benefits of therapies that are chosen based on the molecular profile of the tumor and also from the liquid biopsy....

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel 2022
Subjects:
Medicine and Nursing
Oncology
adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase
breast cancer
cancer
cancer-associated fibroblasts
cfDNA
chemotherapy
circulating free DNA
clinical guideline
clonality classification
comprehensive genomic profiling
CTC
ctDNA
DDR genes
Decision tree
digital enrichment
driver mutation
EGFR mutation
EGFR-TKI
electronic records
epidermal growth factor receptor
extent of resection
gene panel sequencing
glioblastoma prognosis
HNSCC
immune checkpoint inhibitors
immunocytochemistry
immunotherapy
intratumor heterogeneity
laboratory-friendly
liquid biopsy
molecular barcoding
molecular genotyping
multiple biopsies
n/a
new drug development
next-generation sequencing
next-generation sequencing (NGS)
NGS
non-small cell lung cancer
open data
osimertinib
outcome
overall survival
parallel double-detection
PARP inhibitors
PD-L1
pediatric tumors
personalized precision oncology
precision medicine
presumed germline findings
random forest
regulatory reform
resistance
screening
sequencing
smoking
solid cancer
strategic therapeutic intervention
targeted therapy
tDNA
thymoma
TMB
TNBC subtypes
triple-negative breast cancer (TNBC)
tumor evolution
tumor mutational burden
tumor profiling test
tyrosine kinase inhibitor
universal health-care system
whole-exome sequencing
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Internet

Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Similar Items